期刊文献+

胺碘酮诱发甲状腺损伤的机制及治疗研究进展 被引量:4

The Research Progress for Amiodarone-induced Thyroid Gland Injury and Its Teatment
下载PDF
导出
摘要 胺碘酮作为Ⅲ类抗心律失常药,被广泛用于各种心率失常的治疗中。胺碘酮在发挥抗心律失常生物效应的同时,释放大量的碘元素,增加甲状腺合成甲状腺激素的功能,扰乱体内甲状腺激素的正常代谢。并且通过直接的细胞毒性和间接反馈作用,致甲状腺组织损伤。对于胺碘酮诱发的甲状腺组织损伤,可以根据病情采取药物、手术以及放射性碘等相应治疗。 Amiodarone is type Ⅲ antiarrhythmic drug,which generally applied in the treatments of arrhythmia.The amiodarone could release large of iodine while as taking out its antiarrhythmic effect,which increasing the synthesis of thyroid function and disrupting the metabolism process of thyroid hormone.Finally,the thyroid gland get injury.The amiodarone-induced injury may be treated with medicine,surgery and radioactive iodine.
出处 《医学综述》 2011年第12期1853-1855,共3页 Medical Recapitulate
基金 辽宁省自然科学基金(20062102) 辽宁省教育厅项目(2008818)
关键词 胺碘酮 甲状腺功能减低 甲状腺功能亢进 治疗 Amiodarone Amiodarone-induced hypothyroidism Amiodarone-induced thyrotoxicosis Treatment
  • 相关文献

参考文献22

  • 1Singh BN.Amiodarone as paradigm for developing new drugs for atrial fibrillation[J].J Cardiovasc Pharmacol,2008,52(4):300-305.
  • 2Rabkin SW.Effect of amiodarone on phospholipid content and composition in heart,lung,kidney and skeletal muscle:relationship to alteration in thyroid function[J].Pharmacology,2006,76(3):129-135.
  • 3Rao RH,McReady VR,Spathis GS.Iodine kinetic studies during amiodarone treatment[J].J Clini Endocrinol Metabol,1986,62(3):563-567.
  • 4Yamazaki K,Mitsubashi T,Yamada E,et al.Amiodarone reversibly decreases sodium-iodide symporter mRNA expression at,therapeutic concentrations and induces antioxidant responses at supraphysiological concentrations in cultured human thyroid follicles[J].Thyroid,2007,17(12):1189-1200.
  • 5Newman CM,Price A,Davies DW,et al.Amiodarone and the thyroid:a practical guide to the management of thyroid dysfunction induced by amiodarone therapy[J].Heart,1998,79(2):121-127.
  • 6Schenck JB,Rizvi AA,Lin T.Severe primary hypothyroidism manifesting with torsades de pointes[J].Am J Med Sci,2006,331(3):154-156.
  • 7Hofmann A,Nawara C,Ofluoglu S,et al.Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism[J].Wien Klin Wochenschr,2008,120(15/16):493-498.
  • 8Basaria S,Cooper DS.Amiodarone and the thyroid[J].Am J Med,2005,118(7):706-714.
  • 9Tedelind S,Larsson F,Johanson C,et al.Amiodarone inhibits thyroidal iodide transport in vitro by a cyclic adenosine 51-monophosphate and iodine-independent mechanism[J].Endocrinology,2006,147(6):2936-2943.
  • 10Kurnik D,Loebstein R,Farfel Z,et al.Complex drug-drug-disease interactions between amiodarone,warfarin,and the thyroid gland[J].Medicine(Baltimore),2004,83(2):107-113.

同被引文献28

  • 1宋郊,李永清,伏文雪.心脏瓣膜置换术后口服抗凝剂使用PT监测时INR值最适范围的探讨[J].四川医学,2007,28(3):270-271. 被引量:8
  • 2Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused updated incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart diseases[J]. J Am Coll Cardiol, 2008, 52(13): 141-2.
  • 3CARDENAS G A, CABRAL J M, LESLIE C A. Amiodarone-induced thyrotoxicosis: diagnostic and therapeutic strategies[J]. Cleve Clin J Med, 2003, 70(7): 624-631.
  • 4NEWMA C M, PRICE A, DAVIES D W, et al. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy[J]. Heart, 1998, 79(2): 121-127.
  • 5GASSANOV N, DIETLEIN M, CAGLAYAN E, et al. Amiodarone-induced thyroid gland dysfunctions[J]. Dtsch Med Wochenschr, 2010, 135(16): 807-811.
  • 6WENDY T, ROBYN LH. Amiodarone-induced thyrotoxicosis: a review[J]. Can J Cardiol, 2009, 25(7): 421-424.
  • 7WOLFF J. Perchlorate and the thyroid gland[J]. Pharmacol Rev, 1998, 50(1): 89-105.
  • 8朱精强,罗艳丽,龚姝,等.甲状腺功能衰竭法在甲状腺功能亢进手术前准备的前瞻性研究[C].//2007'国际普通外科论坛暨第十四届全国普外基础与.临床进展学术交流大会论文汇编,2007:255-258.
  • 9邢家骝,丁勇,方毅.^131I治疗甲状腺功能亢进症的进展[J].中华内分泌代谢杂志,2010,26(4):265-268. 被引量:14
  • 10朱志强.甲状腺功能亢进手术治疗858例[J].中国现代普通外科进展,2010,13(6):495-496. 被引量:11

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部